Bukwang announces effectiveness of Adipocell in IFATS 2008

Published: 2008-11-03 06:37:00

Updated: 2008-11-03 06:37:00

Bukwang said that Adipocell (allogenic adipose-derived stem cell) injection, which was developed by Anterogen, its affiliate company, is clinically effective in areas such as tissue repair and wound healing in Phase II and III studies which were conducted at Samsung Seoul Hospital between 2004 and 2007.

The clinical trial results were presented in IFATS 2008 meeting, which was held in Toulos...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.